Additionally, we present up-to-date preclinical and clinical studies on low-dose IL-2-based therapy of autoimmune disorders, and focus special attention on suitable dosing and frequency of IL-2 administration in the treatment of autoimmune diseases to avoid inappropriate immune responses. This evidence concerns the gene IL2 and autoimmune disease.